(Q51035347)

27 March 2018

title

High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma. (English)

1 reference

27 March 2018

main subject

immune cell infiltration

1 reference

Raoul A Droeser

1

1 reference

27 March 2018

Uwe Güth

2

1 reference

27 March 2018

Serenella Eppenberger-Castori

3

1 reference

27 March 2018

Sylvia Stadlmann

4

1 reference

27 March 2018

Christian Hirt

5

1 reference

27 March 2018

Luigi Terracciano

6

1 reference

27 March 2018

Gad Singer

7

1 reference

27 March 2018

publication date

28 April 2013

1 reference

27 March 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

27 March 2018

volume

139

1 reference

27 March 2018

issue

8

1 reference

27 March 2018

page(s)

1295-1302

1 reference

27 March 2018

https://scigraph.springernature.com/pub.10.1007/s00432-013-1441-1

exact match

0 references

cites work

Effector memory T cells, early metastasis, and survival in colorectal cancer

1 reference

12 December 2020

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma

1 reference

12 December 2020

The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +/- chemotherapy

1 reference

12 December 2020

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

1 reference

12 December 2020

Glypican-3 expression in primary and recurrent ovarian carcinomas

1 reference

12 December 2020

Tumor microenvironments direct the recruitment and expansion of human Th17 cells

1 reference

12 December 2020

The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer

1 reference

12 December 2020

Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000.

1 reference

12 December 2020

Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments

1 reference

12 December 2020

Innate IL-17-producing cells: the sentinels of the immune system

1 reference

12 December 2020

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

1 reference

12 December 2020

Cancer statistics, 2010

1 reference

12 December 2020

The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans

1 reference

12 December 2020

The Foxp3+ regulatory T cell: a jack of all trades, master of regulation

1 reference

12 December 2020

Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer

1 reference

12 December 2020

Epithelial growth factor receptor status in primary and recurrent ovarian cancer

1 reference

12 December 2020

p53 gene status and chemosensitivity in ovarian cancer

1 reference

12 December 2020

Mast cells and neutrophils release IL-17 through extracellular trap formation in psoriasis

1 reference

12 December 2020

ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancer

1 reference

12 December 2020

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers

1 reference

12 December 2020

Estimates of cancer incidence and mortality in Europe in 2008.

1 reference

12 December 2020

Functional and phenotypic analysis of tumor-infiltrating lymphocytes isolated from human primary and metastatic liver tumors and cultured in recombinant interleukin-2

1 reference

12 December 2020

Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review

1 reference

12 December 2020

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma

1 reference

12 December 2020

Tumor hypoxia and malignant progression.

1 reference

12 December 2020

S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.

1 reference

12 December 2020

The microenvironment of the tumour-host interface

1 reference

12 December 2020

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

1 reference

12 December 2020

Regulatory T cells, tumour immunity and immunotherapy

1 reference

12 December 2020

IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury

1 reference

12 December 2020

Prognostic Role of Histological Necrosis for Nonmetastatic Clear Cell Renal Cell Carcinoma: Correlation With Pathological Features and Molecular Markers

1 reference

12 December 2020

Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha

1 reference

12 December 2020

Lymphoid infiltration as a prognostic variable for early-onset breast carcinomas

1 reference

12 December 2020

Tumor-associated lymphocytes as an independent predictor of response to neoadjuvant chemotherapy in breast cancer.

1 reference

12 December 2020

Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in head and neck cancers

1 reference

12 December 2020

Diverse tumorigenic pathways in ovarian serous carcinoma

1 reference

12 December 2020

Induction and effector functions of T(H)17 cells.

1 reference

12 December 2020

Mesenchymal stem cells in cancer

1 reference

12 December 2020

Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma

1 reference

12 December 2020

Foxp3(+) cell infiltration and granzyme B(+)/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma

1 reference

12 December 2020

Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.

1 reference

12 December 2020

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

12 December 2020

Tissue microarrays in drug discovery

1 reference

12 December 2020

10.1007/S00432-013-1441-1

Identifiers

DOI

1 reference

27 March 2018

PubMed ID

23624523

1 reference

27 March 2018